Event

Discover Cencora at the NLS Days 2024 Conference

September 18-19, 2024 | Conshohocken, PA

Connect with our teams as we convene in Malmö at the Nordic Life Science Days, gathering Nordic and international life science leaders.

Workshop

Investor Gateway to Europe: Demonstrating innovative product value within future EU HTAR framework

Date: Monday 18 September, 2024
Time: 10:00am – 11:00am
Moderator: Herbert Altmann, VP Market Access & Healthcare Consulting Europe, Cencora

3,000+
expert consultants worldwide
1,300+
global locations
25+
years of experience

One expert partner, from global strategy to local implementation

We invest in understanding your situation to provide a tailored solution that empowers global patient access.

Achieve local reimbursement globally

We can help you devise a global strategy and then tailor it to the unique requirements of each market for a coordinated and thoughtful approach to access.

Maximize product value

We go beyond the average partner as experts in both market access strategy and generating the evidence (i.e., we can be both scientific in our thinking and commercial in our approach).

Navigate Health Technology Assessments (HTAs)

We work through the complex HTA processes in different countries, helping our clients’ products meet the specific requirements of each assessment.

Commercialization services

Our team of international healthcare experts offers flexible, integrated capabilities to provide unmatched support worldwide. We use our deep industry knowledge and network of connections to help you to plan and execute your commercialization strategy.

Cell and Gene Therapy

We partner with manufacturers to address the unique challenges of bringing cell and gene therapies to market. We leverage our collective and extensive expertise in specialty logistics, reimbursement and hub services to drive outcomes for our customers.

Demonstrate your value to investors

Our tailored strategies and detailed analysis can support your selling journey. We help you develop a compelling narrative that is pressure-tested for impact with key stakeholders, to help position you for success.

Emerging biopharma Outlook Therapeutics shares the benefits of Cencora's international commercialization support

Explore the impact of strategic alliances in biopharma commercialization. An emerging company joined forces with Cencora, a leading commercialization solutions provider, to successfully enter European markets and aim for global expansion.

Innovations to Market

Accelerating speed to market
Our integrated Innovations to Market (ITM) solutions support you wherever you are in the clinical through commercialization journey. A single point of entry that offers adaptable, early interactions with experts to lay the groundwork for market access, from the start.

Integrated Product Development

Unlocking your product success from early discovery through development
Preparing to navigate the complexities of launching a product can be challenging. To successfully progress your product through its development and commercialization journey, you need the strategic guidance of a global partner. Our Integrated Product Development (IPD) solution can help.
Available in English only

Catch up on the latest HTA Quarterly news

Gain insights from our experts around evolving global health technology assessment (HTA) priorities, and browse our issues.

Start a conversation

Our consultative approach and extensive reach across healthcare give us access to the best insights in the industry- insights we leverage to help commercialization challenges for our partners and patients they serve.

Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.

Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.